These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3485432)

  • 1. Abnormal B cell function in patients with Behçet's disease.
    Suzuki N; Sakane T; Ueda Y; Tsunematsu T
    Arthritis Rheum; 1986 Feb; 29(2):212-9. PubMed ID: 3485432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Studies of the mechanisms of human B-cell activation. IV. Abnormalities at the B-cell level in patients with Behçet's disease].
    Suzuki N; Sakane T; Takada S; Ueda Y; Murakawa Y; Tsunematsu T; Tsuchiya T; Niwa Y
    Ryumachi; 1985 Apr; 25(2):95-102. PubMed ID: 3875902
    [No Abstract]   [Full Text] [Related]  

  • 3. Aspects of lymphocyte function in Behçet's disease.
    Haim S; Mekori T; Sobel JD; Robinson E
    Dermatologica; 1976; 153(1):34-7. PubMed ID: 1086808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional aberration of T cell subsets in patients with Behçet's disease.
    Sakane T; Kotani H; Takada S; Tsunematsu T
    Arthritis Rheum; 1982 Nov; 25(11):1343-51. PubMed ID: 6215926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormalities of T-cell subsets in Behçet's syndrome.
    Lim SD; Haw CR; Kim NI; Fusaro RM
    Arch Dermatol; 1983 Apr; 119(4):307-10. PubMed ID: 6220679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunological study of Behcet's disease].
    Kawai K; Masuda K; Akimoto T
    Bull Soc Pathol Exot Filiales; 1978; 71(2):221-6. PubMed ID: 311255
    [No Abstract]   [Full Text] [Related]  

  • 7. Behçet's disease: clinical and immunological response to immunosuppressive therapy. A case report.
    Rimon D; Lahat N; Nir E; Cohen L
    Isr J Med Sci; 1985 Jan; 21(1):57-61. PubMed ID: 3156102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell-mediated immune functions and immunoregulatory cells in Behçet's syndrome.
    Victorino RM; Ryan P; Hughes GR; Hodgson HJ
    Clin Exp Immunol; 1982 Apr; 48(1):121-8. PubMed ID: 6211313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic signs of memory B cell activation in patients with Behçet's disease are partially restored by anti-tumour necrosis factor treatment.
    van der Houwen TB; van Hagen PM; Timmermans WM; Bartol SJ; Lam KH; Kappen JH; van Zelm MC; van Laar JA
    Rheumatology (Oxford); 2017 Jan; 56(1):134-144. PubMed ID: 27744360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-6 (IL-6) in patients with Behçet's disease.
    Yamakawa Y; Sugita Y; Nagatani T; Takahashi S; Yamakawa T; Tanaka S; Nakamura S; Ohno S; Sekihara H; Okuda K; Nakajima H
    J Dermatol Sci; 1996 Mar; 11(3):189-95. PubMed ID: 8785169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative, immunological studies on lymphangiectasia of the small intestine revealed in protein losing gastroenteropathy and Behçet's disease.
    Tsuchiya M; Hibi T; Mizuno Y; Ono A; Morita A
    Gastroenterol Jpn; 1976; 11(2):88-99. PubMed ID: 1086265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphocyte studies in Behçet's syndrome.
    Ahmed AR
    Dermatologica; 1982 Mar; 164(3):175-80. PubMed ID: 6979484
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of T cell subsets in Behçet's syndrome using anti-T cell monoclonal antibodies.
    Valesini G; Pivetti-Pezzi P; Mastrandrea F; Moncada A; Cuomo M; Natali PG
    Clin Exp Immunol; 1985 Apr; 60(1):55-60. PubMed ID: 3874016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural killer cell numbers and function in peripheral lymphoid cells in Behcet's disease.
    Kaneko F; Takahashi Y; Muramatsu R; Adachi K; Miura Y; Nakane A; Minagawa T
    Br J Dermatol; 1985 Sep; 113(3):313-8. PubMed ID: 4063167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cellular immune status and microphage function in Behçet's disease].
    Djawari D; Hornstein OP
    Z Hautkr; 1980 Mar; 55(5):271-92. PubMed ID: 6996366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of interleukin-2 activity in patients with Behçet's disease. Ability of T cells to produce and respond to interleukin-2.
    Sakane T; Suzuki N; Ueda Y; Takada S; Murakawa Y; Hoshino T; Niwa Y; Tsunematsu T
    Arthritis Rheum; 1986 Mar; 29(3):371-8. PubMed ID: 3083826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of human recombinant interferon-alpha2a (rhIFN-alpha2a) on altered lymphocyte subpopulations and monocytes in Behcet's disease.
    Treusch M; Vonthein R; Baur M; Günaydin I; Koch S; Stübiger N; Eckstein AK; Peter HH; Ness T; Zierhut M; Kötter I
    Rheumatology (Oxford); 2004 Oct; 43(10):1275-82. PubMed ID: 15252211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between IL-17A/F, IL-23, IL-35 and IL-12/-23 (p40) levels in peripheral blood lymphocyte cultures and disease activity in Behcet's patients.
    Sonmez C; Yucel AA; Yesil TH; Kucuk H; Sezgin B; Mercan R; Yucel AE; Demirel GY
    Clin Rheumatol; 2018 Oct; 37(10):2797-2804. PubMed ID: 29557072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behçet's disease sera containing antiendothelial cell antibodies promote adhesion of T lymphocytes to cultured human dermal microvascular endothelial cells.
    Lee KH; Chung HS; Bang D; Lee S
    Yonsei Med J; 1999 Apr; 40(2):152-8. PubMed ID: 10333719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma endothelin-1 concentrations in patients with Behçet's disease.
    Ural AU; Yalcin A; Beyan C; Isimer A; Bayhan H
    Scand J Rheumatol; 1994; 23(6):322-5. PubMed ID: 7801056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.